An observational study in Chronic Pancreatitis and Pancreatic Cancer, sponsored by Indiana University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-09-05.
Sponsored by Indiana University · Observational
The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.
268 studies on the registry are indexed under Pancreatitis, Chronic; 75 are open to participants now.
This study's enrollment of 127 is below the median of 293 across 116 observational studies indexed under Pancreatitis, Chronic.
Browse Pancreatitis, Chronic studies →Indiana University is the lead sponsor of 982 studies on the registry; 199 are open to participants now.
Of its 148 completed or terminated interventional studies of FDA-regulated products, 117 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with abdominal pain from documented chronic pancreatitis or pancreatic cancer that are referred for EUS-guided celiac block.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
subjects who are getting a celiac block for chronic pancreatitis
Drug: triamcinolone
subjects who are getting a celiac block for pancreatic cancer
Drug: 98% dehydrated alcohol
80mg of triamcinolone injected into the celiac ganglion during the EUS-CB
Also known as: Kenalog 80mg
10ml of 98% dehydrated alcohol injected into the celiac ganglion during the EUS-CB
The record gives a start of Jun 2002, a primary completion of Dec 2012 and a completion of Dec 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.